CAM-3001

MedImmune Cambridge-derived Clinical Development
Partners	Product	Target	Disease	PreC	PhI	PhII	PhIII	Fld	Mkt
CAT/Zenyth	CAM-3001	GM-CSF receptor	rheumatoid arthritis

Key to table

CAM-3001 is an anti-GM-CSF receptor human monoclonal antibody. This product is being developed jointly with Zenyth Therapeutics (acquired by CSL) and is currently in Phase I development for the potential treatment of rheumatoid arthritis.